|
TMEM14B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.63666907488414E-12 |
| Normal-vs-Stage2 |
5.49829999973994E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.90736315630602E-12 |
| Stage1-vs-Stage2 |
8.842800E-01 |
| Stage1-vs-Stage3 |
3.211300E-04 |
| Stage1-vs-Stage4 |
5.769900E-02 |
| Stage2-vs-Stage3 |
3.875600E-02 |
| Stage2-vs-Stage4 |
2.446000E-01 |
| Stage3-vs-Stage4 |
2.321200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
9.1746000019377E-08 |
| Normal-vs-Asian |
8.562200E-04 |
| Caucasian-vs-AfricanAmerican |
5.579600E-01 |
| Caucasian-vs-Asian |
6.774400E-01 |
| AfricanAmerican-vs-Asian |
5.629400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.00900399147008E-11 |
| Male-vs-Female |
5.785500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.56359999953426E-07 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
2.3090418466154E-12 |
| Normal-vs-Age(81-100Yrs) |
8.101100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.802000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.026600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.070800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.945200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.356000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.278000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.52020000000675E-05 |
| Normal-vs-Grade 2 |
2.72115663335626E-13 |
| Normal-vs-Grade 3 |
1.62492241884138E-12 |
| Normal-vs-Grade 4 |
1.62481139653892E-12 |
| Grade 1-vs-Grade 2 |
7.180600E-01 |
| Grade 1-vs-Grade 3 |
2.517800E-01 |
| Grade 1-vs-Grade 4 |
7.075600E-02 |
| Grade 2-vs-Grade 3 |
1.429620E-01 |
| Grade 2-vs-Grade 4 |
2.180000E-03 |
| Grade 3-vs-Grade 4 |
4.576400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.5773827516673E-12 |
| Normal-vs-ccB subtype |
1.63324909152607E-12 |
| ccA subtype-vs-ccB subtype |
1.459930E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.70672373403613E-12 |
| Normal-vs-N1 |
1.9285899999999E-05 |
| N0-vs-N1 |
5.172600E-01 |
|
|
